Licchetta L, Vignatelli L, Toni F, Teglia A, Beatrice Belotti LM, Ferri L, Menghi V, Mostacci B, Di Vito L, Bisulli F, Tinuper P. Long-term Outcome of Epilepsy and Cortical Malformations Due to Abnormal Migration and Postmigrational Development: A Cohort Study.
Neurology 2022;
99:e23-e32. [PMID:
35410907 DOI:
10.1212/wnl.0000000000200352]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Accepted: 02/21/2022] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE
To evaluate the long-term outcome of patients with epilepsy and malformations of cortical development (MCD).
METHODS
We conducted a historical cohort study of patients with epilepsy and MCD due to impaired neuronal migration and postmigration organization, and with a follow-up period of ≥5 years. For each patient, MCD was classified after accurate neuroimaging reappraisal by an expert neuroradiologist. The primary outcome was remission, defined as a period of seizure freedom ≥5 years at any time from epilepsy onset. We used Kaplan-Meier estimates for survival analysis, and univariate and multivariate Cox regression analyses to evaluate baseline variables as possible factors associated with remission.
RESULTS
The cohort included 71 patients (M/F=31/40) with a 17-year median follow-up (1506 person-years). About half (49.3%) had heterotopia, 35.2% polymicrogyria, 7% lissencephaly and 8.5% had the combination of two MCD. The mean age at seizure onset was 12.4±7.2 years. Intellectual disability and neurological deficits were observed in 30.4% and 40.9%, respectively. More than 60% of patients had refractory epilepsy. In three patients who underwent epilepsy surgery, MCD diagnosis was confirmed by histology. At last visit, 44% of patients had been seizure-free during the previous year, however none of them had stopped anti-seizure medication. Thirty patients achieved remission (Remission group, 42.2%) at some point in their disease history, whereas 41 individuals (Non Remission group, 57.8%) had never been in remission for ≥5 years. The cumulative remission rate was 38% by 20 years from inclusion. In the Cox model, unilateral distribution of MCD (HR: 2.68, 95% CI: 1.04-6.92) and a low seizure frequency at onset (HR: 5.01, 95% CI: 1.12-22.5) were significantly associated with remission.
CONCLUSIONS
Patients with epilepsy and MCD showed a remission rate of 38% by 20 years from onset. Unilateral distribution of the MCD is associated with a three-fold probability of achieving remission. About 40% of patients showed a drug-sensitive condition with risk of relapse during their epilepsy course.
CLASSIFICATION OF EVIDENCE
This study provides Class II evidence that in patients with epilepsy and MCD, unilateral MCD and low seizure frequency at onset are associated with achieving epilepsy remission.
Collapse